Crystalline salts of (S)-6-((1 acetylpiperidin-4-yl)amino)-N-(3-(3,4-dihydroisoquinolin-2(1H)-yl)-2-hydroxypropyl)pyrimidine-4-carboxamide

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9884846
SERIAL NO

15318714

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Disclosed are novel crystalline salts of (S)-6-((1-acetylpiperidin-4-yl)amino)-N-(3-(3,4-dihydroisoquinolin-2(1H)-yl)-2-hydroxypropyl)pyrimidine-4-carboxamide and pharmaceutical compositions containing the same. Also disclosed are processes for the preparation thereof and methods for use thereof.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITEDGSK MEDICINES RESEARCH CENTRE GUNNELS WOOD ROAD STEVENAGE SG1 2NY

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Clark, William M King of Prussia, US 7 73
Sathe, Rajendra S Collegeville, US 2 7

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Aug 6, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Aug 6, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00